Department of Biochemistry, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI 53226, USA.
Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA; Center for Pharmacogenomics, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Stem Cell Reports. 2019 Feb 12;12(2):395-410. doi: 10.1016/j.stemcr.2018.12.016. Epub 2019 Jan 24.
Several protocols now support efficient differentiation of human pluripotent stem cells to cardiomyocytes (hPSC-CMs) but these still indicate line-to-line variability. As the number of studies implementing this technology expands, accurate assessment of cell identity is paramount to well-defined studies that can be replicated among laboratories. While flow cytometry is apt for routine assessment, a standardized protocol for assessing cardiomyocyte identity has not yet been established. Therefore, the current study leveraged targeted mass spectrometry to confirm the presence of troponin proteins in day 25 hPSC-CMs and systematically evaluated multiple anti-troponin antibodies and sample preparation protocols for their suitability in assessing cardiomyocyte identity. Results demonstrate challenges to interpreting data generated by published methods and inform the development of a robust protocol for routine assessment of hPSC-CMs. The data, workflow for antibody evaluation, and standardized protocol described here should benefit investigators new to this field and those with expertise in hPSC-CM differentiation.
目前有几种方案支持高效率地将人类多能干细胞分化为心肌细胞(hPSC-CMs),但这些方案仍然存在细胞系间的可变性。随着实施这项技术的研究数量不断增加,准确评估细胞身份对于可在实验室间复制的明确研究至关重要。尽管流式细胞术适合常规评估,但尚未建立用于评估心肌细胞身份的标准化方案。因此,本研究利用靶向质谱法确认了第 25 天 hPSC-CMs 中肌钙蛋白蛋白的存在,并系统评估了多种抗肌钙蛋白抗体和样本制备方案,以评估其用于评估心肌细胞身份的适用性。结果表明,对已发表方法产生的数据进行解释存在挑战,并为常规评估 hPSC-CMs 开发了一种稳健的方案。此处描述的数据、抗体评估工作流程和标准化方案应使该领域的新手和具有 hPSC-CM 分化专业知识的人员受益。